Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders
- PMID: 31279014
- DOI: 10.1016/j.jaad.2019.06.1297
Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders
Comment on
-
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.J Am Acad Dermatol. 2020 Mar;82(3):612-621. doi: 10.1016/j.jaad.2019.05.098. Epub 2019 Jun 8. J Am Acad Dermatol. 2020. PMID: 31185230 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
